A.A. Khalil Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
A.A. Khalil's research interests include the analysis of risk factors for specific medical conditions and the evaluation of treatment efficacy. Recent publications investigate the association of genetic polymorphisms with atherosclerosis and the prediction of outcomes in non-small cell lung cancer (NSCLC) based on early response to chemotherapy. Additionally, research has examined risk factors for radiation pneumonitis in modern adaptive radiotherapy and the comparative effectiveness of palbociclib plus endocrine therapy versus chemotherapy in premenopausal women with advanced breast cancer.
Metrics
- Publications: 4
Selected Publications
-
Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Polymorphism with Atherosclerosis: A Bibliometric Analysis (2025)
Collaboration Network
Top Collaborators
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PD-0664 Risk factors of radiation pneumonitis in modern adaptive radiotherapy
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC
- PD-0664 Risk factors of radiation pneumonitis in modern adaptive radiotherapy
- PD-0664 Risk factors of radiation pneumonitis in modern adaptive radiotherapy
Similar Researchers
Based on overlapping research topics